¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02
±³À°ÀÏÀÚ : 2019-11-02
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø  
±³À°ÁÖÁ¦ : ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º°
¿¬¶ôó : 02-565-3350  
À̸ÞÀÏ : ksh@koreanhypertension.org      
±³À°Á¾·ù : ³»°ú, Á¤Çü¿Ü°ú, ÈäºÎ¿Ü°ú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í »çÀüµî·Ï 1¸¸¿ø / ÇöÀåµî·Ï 2¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 08:30~08:45 History of pulmonary hypertension  ¹ÚÀçÇü(Ãæ³²ÀÇ´ë ¼øȯ±â ³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 08:45~09:00 Epidemiology of pulmonary hypertension and suggestion for Korean registry  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë ¼øȯ±â ³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:00~09:15 Genetic evaluation of pulmonary hypertension and its clinical implication  ÀÌ¿µÀç(°¡ÃµÀÇ´ë »ýÈ­Çаú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:15~09:30 Combination treatment of selective pulmonary vasodilator for pulmonary hypertension  Á¤Á¶¿ø(¿¬¼¼ÀÇ´ë ¼Ò¾Æ½ÉÀå°ú) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:30~09:45 Discussion  ÃÖ¼ºÀç °í·ÁÀÇ´ë ·ù¸¶Æ¼½º³»°ú/Àå¼ÒÀÍ ¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú/Çã¶õ ÇѾçÀÇ´ë ½ÉÀå³»°ú(ÃÖ¼ºÀç °í·ÁÀÇ´ë ·ù¸¶Æ¼½º³»°ú/Àå¼ÒÀÍ ¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú/Çã¶õ ÇѾçÀÇ´ë ½ÉÀå³»°ú) 
È޽Ġ11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:45~10:05 Coffee break  () 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:05~10:20 CTEPH 2019  Hiromi Matsubara(National Hospital Organization Okayama Medical Center) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:20~10:35 Medical devices for pulmonary hypertension  ¼ÛÁø¿µ(¼º±Õ°üÀÇ´ë ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:35~10:50 Surgical treatment for pulmonary hypertension  À±¿µ³²(¿¬¼¼ÀÇ´ë ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:50~11:05 Anesthesiology for the patients with pulmonary hypertension  À念Àº(¼­¿ïÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:05~11:20 Discussion  ¼ÕÀϼ® °æÈñÀÇ´ë ¼øȯ±â³»°ú/Àº¿µ¹Î °­³²¼¼ºê¶õ½ºº´¿ø ¼Ò¾Æ½ÉÀå°ú/À̼®ÀÎ °¡ÃµÀÇ´ë ÈäºÎ¿Ü°ú(¼ÕÀϼ® °æÈñÀÇ´ë ¼øȯ±â³»°ú/Àº¿µ¹Î °­³²¼¼ºê¶õ½ºº´¿ø ¼Ò¾Æ½ÉÀå°ú/À̼®ÀÎ °¡ÃµÀÇ´ë ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:20~11:35 Taiwan PH Guideline  Kuo Yang Wang(Taichung China Medical University Hospital) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:35~11:50 Japan PH Guideline  Takeshi Ogo(National Cerebral and Cardiovascular Center) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:50~12:05 China PH Guideline  Zhi-Cheng Jing(Fu Wai Hospital & National Center for Cardiovascular disease) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 12:05~12:20 Proposed Ideas of EASOPH PH Guideline  Wook-Jin Chung(Gachon University Gil Medical Center) 
½Ä»ç 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 12:20~13:20 Lunch  () 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 13:20~13:40 Pulmonary hypertension in my life  ³ëÁ¤ÀÏ(¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 13:40~14:10 How can we diagnose and treat the patients of Pulmonary Hypertension in Heart Failure  Stephan Rosenkranz(University of Cologne) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 14:10~14:40 Could we recommend pregnancy in female PAH patient?  Hiromi Matsubara(National Hospital Organization Okayama Medical Center) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 14:40~14:50 Discussion  ÃÖÁø¿À ¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú/³ªÁø¿À °í·ÁÀÇ´ë ¼øȯ±â³»°ú/À§Áø °¡ÃµÀÇ´ë ½ÉÀå³»°ú/ÀÌÁÖÈñ ÃæºÏÀÇ´ë ¼øȯ±â³»°ú(ÃÖÁø¿À ¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú/³ªÁø¿À °í·ÁÀÇ´ë ¼øȯ±â³»°ú/À§Áø °¡ÃµÀÇ´ë ½ÉÀå³»°ú/ÀÌÁÖÈñ ÃæºÏÀÇ´ë ¼øȯ±â³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 14:50~15:05 Transition of pediatric patient with pulmonary hypertension  ±è±â¹ü(¼­¿ïÀÇ´ë ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:05~15:20 Pregnancy and delivery in the patients with pulmonary hypertension  ±è¹ÌÁ¤(°¡Å縯ÀÇ´ë ÀÎõ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:20~15:35 Psychosocial support for patients with pulmonary hypertension  ÀÌÁ¤(¼­¿ïÀÇ´ë ½Å°æÁ¤½Å°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:35~15:50 Palliative care for the patients with advanced pulmonary hypertension  ±è¹Î¼±(¼­¿ïÀÇ´ë ¿ÏÈ­ÀÇ·á) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:50~16:05 Discussion  ¹ÚÂù¼® °¡Å縯ÀÇ´ë ¼øȯ±â³»°ú/³ª½Â¿ø ¿ï»êÀÇ´ë È£Èí±â³»°ú/¾È°æÁø °¡ÃµÀÇ´ë ¼Ò¾Æû¼Ò³â°ú(¹ÚÂù¼® °¡Å縯ÀÇ´ë ¼øȯ±â³»°ú/³ª½Â¿ø ¿ï»êÀÇ´ë È£Èí±â³»°ú/¾È°æÁø °¡ÃµÀÇ´ë ¼Ò¾Æû¼Ò³â°ú) 
È޽Ġ11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:05~16:25 Coffee break  () 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:25~16:35 PH with uncorrected CHD  ¾ÈÈ¿¼ø(¼­¿ï´ë º¸¶ó¸Åº´¿ø ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:35~16:45 PH with left heart disease  Á¤Çý¹®(°æÈñÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:45~16:55 PH with connective disease  °­ÁöÇö(Àü³²ÀÇ´ë ·ù¸¶Æ¼½º³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:55~17:05 PH with liver disease  À念¿ì(°¡ÃµÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 17:05~17:15 PH with lung disease  ÀÌÀç½Â(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 17:15~17:25 PH with post-operative CHD  À±ÀÚ°æ(¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 17:25~17:45 Discussion  À¯½Â±â À»ÁöÀÇ´ë ¼øȯ±â³»°ú/¼­Çý¼± ¼øõÇâÀÇ´ë ¼øȯ±â³»°ú/±è¼öÇö ¼­¿ïÀÇ·á¿ø È£Èí±â³»°ú(À¯½Â±â À»ÁöÀÇ´ë ¼øȯ±â³»°ú/¼­Çý¼± ¼øõÇâÀÇ´ë ¼øȯ±â³»°ú/±è¼öÇö ¼­¿ïÀÇ·á¿ø È£Èí±â³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø Â÷ÀÇ°úÇдëÇб³ ÀÓ»óÀÇÇÐ ½ÉÆ÷Áö¿ò(1) : 2019-11-02
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø Yonsei Lung Transplant Academy 2019 : 2019-11-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
105 °æ³² ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ 2018 Post Graduate Asthma School (1ÀÏÂ÷) : 2018-08-25 0 412 2018-07-28
104 ÀÎõ Á¦8Â÷ °¡Å縯´ëÇб³ ÀÎõ¼º¸ðº´¿ø È£Èí±â³»°ú ±â°èȯ±â ¿öÅ©¼ó : 2018-08-25 0 1,258 2018-07-28
103 ¼­¿ï ´ëÇѼҾƽŰæÇÐȸ Fellowship in Training : 2018-08-25 0 533 2018-07-28
102 °æ±â Á¦5Â÷ ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ ¿öÅ©¼ó(ASGO 5th International Workshop on Gynecologic Oncology in conjunction with 12th KSGO Workshop for Young Gynecologic Oncologists) : 2018-08-25 0 329 2018-07-28
101 ¼­¿ï 2018³â ´ëÇѺÎÀ§¸¶ÃëÇÐȸ Á¦2ȸ Çмú´ëȸ : 2018-08-25 0 468 2018-07-28
100 ÀüºÏ Á¦ 67ȸ Çѳ² ÇǺΰúÇÐȸ Çмú´ëȸ : 2018-08-25 0 1,070 2018-07-28
99 °æºÏ Ä¥°î°æºÏ´ëÇб³º´¿ø °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶ÃëÅëÁõÀÇÇаú ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-25 0 629 2018-07-28
98 °æ±â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦3ȸ ÇÚÁî¿Â ¿öÅ©¼ó Á¦1ºÎ : 2018-08-25 0 365 2018-07-28
97 °æ±â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦3ȸ ÇÚÁî¿Â ¿öÅ©¼ó Á¦2ºÎ : 2018-08-25 0 878 2018-07-28
96 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Live Surgery with Epiduroscopy : 2018-08-24 0 331 2018-07-28
95 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-24 0 311 2018-07-28
94 ÃæºÏ ±¹¸³ÀÇ·á¿ø ÃÊÀ½ÆÄ À¯µµÇÏ ½Ã¼ú ¹× ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ ¿ª·® °­È­ : 2018-08-24 0 357 2018-07-28
93 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Summer Intensive Course 2018 of KSIN : 2018-08-24 0 387 2018-07-28
92 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-24 0 305 2018-07-28
91 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/24) : 2018-08-24 0 322 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷